164 related articles for article (PubMed ID: 6512004)
21. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
Allen RM; Lane JD; Brauchi JT
Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
[TBL] [Abstract][Full Text] [Related]
22. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
Morgan DG; Sinha YN; Finch CE
Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
[TBL] [Abstract][Full Text] [Related]
23. Phenytoin potentiation of neuroleptic-induced dyskinesias.
Sethi KD; Hitri A; Diamond BI
Mov Disord; 1990; 5(4):325-7. PubMed ID: 2147979
[TBL] [Abstract][Full Text] [Related]
24. Mesolimbic and striatal dopamine receptor supersensitivity: prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG).
Chiu P; Rajakumar G; Chiu S; Johnson RL; Mishra RK
Peptides; 1985; 6(2):179-83. PubMed ID: 2863809
[TBL] [Abstract][Full Text] [Related]
25. Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug.
Severson JA; Robinson HE; Simpson GM
Psychopharmacology (Berl); 1984; 84(1):115-9. PubMed ID: 6149590
[TBL] [Abstract][Full Text] [Related]
26. Hypophysectomy fails to affect the supersensitivity of striatal dopamine target cells induced by prolonged haloperidol treatment.
Scatton B; Fage D
Eur J Pharmacol; 1984 Feb; 98(1):1-7. PubMed ID: 6538845
[TBL] [Abstract][Full Text] [Related]
27. Aging and the regulation of striatal dopaminergic mechanisms in mice.
Randall PK; Severson JA; Finch CE
J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
[TBL] [Abstract][Full Text] [Related]
28. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
29. Dopamine agonist potencies of ergolines.
Lew JY; Nakamura S; Battista AF; Goldstein M
Commun Psychopharmacol; 1979; 3(3):179-83. PubMed ID: 115634
[No Abstract] [Full Text] [Related]
30. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives.
Gundlach AL; Christie MJ; Beart PM
Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029
[TBL] [Abstract][Full Text] [Related]
31. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.
Meller E; Bohmaker K; Rosengarten H; Friedhoff AJ
Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646
[TBL] [Abstract][Full Text] [Related]
32. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
Prasad C; Spahn SA; Ikegami H
Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303
[TBL] [Abstract][Full Text] [Related]
33. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
Raiteri M; Cerrito F; Casazza G; Levi G
Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
[No Abstract] [Full Text] [Related]
34. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
Chiu S; Paulose CS; Mishra RK
Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
[TBL] [Abstract][Full Text] [Related]
35. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
Sprah L; Zivin M; Sket D
J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
[TBL] [Abstract][Full Text] [Related]
36. Prenatal haloperidol alters striatal dopamine and opiate receptors.
Moon SL
Brain Res; 1984 Dec; 323(1):109-13. PubMed ID: 6098328
[TBL] [Abstract][Full Text] [Related]
37. Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment.
Agnati LF; Fuxe K; Benfenati F; Battistini N; Zini I; Toffano G
Neurosci Lett; 1983 Oct; 40(3):293-7. PubMed ID: 6646502
[TBL] [Abstract][Full Text] [Related]
38. Individual differences in the response of dopamine receptor number to chronic haloperidol treatment.
Bannet J; Belmaker RH; Ebstein RP
Biol Psychiatry; 1981 Nov; 16(11):1059-65. PubMed ID: 7349620
[TBL] [Abstract][Full Text] [Related]
39. Dopamine receptor mediated inhibition by pergolide of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: slight effect of ascorbate.
Lehmann J; Arbilla S; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):31-5. PubMed ID: 7279007
[TBL] [Abstract][Full Text] [Related]
40. Effects of intermittent haloperidol treatment on dopamine receptor sensitivity in guinea pigs.
Koller WC
Psychopharmacology (Berl); 1984; 84(1):98-100. PubMed ID: 6436898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
